Ingelheim/Cologne, 30 November 2017.
Boehringer Ingelheim, one of the world‘s leading research-driven pharmaceutical companies, has signed a global license agreement to use the “enterprise:inmation” industrial information management system from inmation Software GmbH, a technology leader in real-time information management solutions for large scale industries. The license agreement will enable Boehringer Ingelheim to create uniform real-time data infrastructure at all of its production facilities around the globe. Prior to conclusion of the contract Boehringer Ingelheim has tested the software in an in-depth evaluation for several months. In addition, as one of the first users from the pharmaceutical industry, Boehringer Ingelheim will join the advisory board of inmation Software to help further develop the management system to continue to meet the advanced needs of the industry.